APA (7th ed.) Citation

K, G., QG, K., SA, T. D., CS, W., L, Z., Q, S., . . . GD, L. (2023). Aldose reductase inhibition alleviates diabetic cardiomyopathy and is associated with a decrease in myocardial fatty acid oxidation. Cardiovascular diabetology, 22(1), 73. https://doi.org/10.1186/s12933-023-01811-w

Chicago Style (17th ed.) Citation

K, Gopal, et al. "Aldose Reductase Inhibition Alleviates Diabetic Cardiomyopathy and Is Associated with a Decrease in Myocardial Fatty Acid Oxidation." Cardiovascular Diabetology 22, no. 1 (2023): 73. https://doi.org/10.1186/s12933-023-01811-w.

MLA (9th ed.) Citation

K, Gopal, et al. "Aldose Reductase Inhibition Alleviates Diabetic Cardiomyopathy and Is Associated with a Decrease in Myocardial Fatty Acid Oxidation." Cardiovascular Diabetology, vol. 22, no. 1, 2023, p. 73, https://doi.org/10.1186/s12933-023-01811-w.